Advancing Care for Chronic Kidney Disease

In January 2025, NCQA convened a panel of experts—primary care clinicians, nephrologists, cardiologists, endocrinologists, pharmacists, patient representatives—to discuss ways to drive improvement in the quality of care for people with CKD. This white paper captures the dynamic discussions and insights from the convening, presenting actionable recommendations to close CKD care gaps and charting a roadmap for future quality measures.

Advancing Care for Chronic Kidney Disease

Thanks to our panel of experts for sharing their knowledge and insights. This research is made possible with support from Boehringer Ingelheim and Novo Nordisk.

expand all

Kidney Health Evaluation for Patients With Diabetes (Total)

Measurement Year	Commercial HMO	Commercial PPO	Medicaid HMO	Medicare HMO	Medicare PPO
2023	49.5	42.9	37.7	52.9	49.4
2022	45.8	40.1	34.5	47.5	42.9
2021	43.9	39.6	33.5	44.2	40.3

This State of Healthcare Quality Report classifies health plans differently than NCQA’s Quality Compass. HMO corresponds to All LOBs (excluding PPO and EPO) within Quality Compass. PPO corresponds to PPO and EPO within Quality Compass.

Figures do not account for changes in the underlying measure that could break trending. Contact Information Products via my.ncqa.org for analysis that accounts for trend breaks.

References

Centers for Disease Control and Prevention (CDC). 2020. “Diabetes Basics.” https://www.cdc.gov/diabetes/basics/diabetes.html
2021. “Diabetes and Chronic Kidney Disease.” US Department of Health and Human Services. https://www.cdc.gov/diabetes/managing/diabetes-kidney-disease.html
“Chronic Kidney Disease in the United States, 2021.” Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2021. https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html